Date Initiated by Firm |
July 29, 2013 |
Date Posted |
August 23, 2013 |
Recall Status1 |
Terminated 3 on July 16, 2014 |
Recall Number |
Z-2049-2013 |
Recall Event ID |
65841 |
Product Classification |
Enzyme immunoassay, amphetamine - Product Code DKZ
|
Product |
SARKEN STAT! Multi-Drug Test Panel
Product Usage- Labeled as FOR FORENSIC USE ONLY (Employee, Student or Probation Testing).
|
Code Information |
Manufacturer's Product Number DOA-254 Lot Number DOA2050035 DOA2090666 DOA2110059 DOA2120771 Expiration Date: 02/2014 07/2014 08/2014 10/2014 |
Recalling Firm/ Manufacturer |
Sarken, Inc. 720 S Smith Rd STE 101 Tempe AZ 85281-2925
|
For Additional Information Contact |
480-894-1255
|
Manufacturer Reason for Recall |
These products are being recalled because they were distributed without adequate labeling and instructions for use. Inadequate labeling could lead to misuse of the Test Kits and incorrect test results.
|
FDA Determined Cause 2 |
Other |
Action |
Firm notified customers via telephone, followed up with MEDICAL DEVICE RECALL letter dated July 29, 2013 sent 08/02/13, via USPS regular mail to all affected customers. The recall notification letter is accompanied by a return response, acknowledgement and receipt form. The letter notify customers of the voluntary recall, product description (with prodcut images), reason for recall, potential impact, instructions/actions to follow, and contact information. |
Quantity in Commerce |
various quantities |
Distribution |
Worldwide Distribution - US Nationwide in the country Virgin Islands |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|